Eligible women in S’pore to get subsidised access to broader HPV9 vaccine from 2027
Starting January 2027, Singapore will provide subsidized access to the Gardasil 9 vaccine to protect against 90% of cervical cancers. The program includes school-based vaccinations and means-tested subsidies for adults.
Why it matters
This is a major update to national immunization schedules aimed at reducing long-term cancer rates through broader vaccine coverage.
Those who started their vaccination series with HPV2 or HPV4, and are pending further doses, may complete it by receiving the HPV9 vaccine.
Listen Summarise From Jan 1, 2027, eligible women in Singapore can receive the Gardasil 9 (HPV9) vaccine at subsidised rates to protect against up to 90% of cervical cancers. Secondary 1 and 2 girls will be vaccinated with HPV9 in schools instead of the HPV2 vaccine, with subsidies and MediSave support available. The HPV vaccination schedule now recommends two or three doses depending on age, allows mixed vaccine completion, and excludes additional doses for those already fully vaccinated. AI generated
SINGAPORE – Eligible women looking to guard against cervical cancer will be able to get the Gardasil 9 vaccine, which offers broader protection against the human papillomavirus (HPV) , at a subsidised rate in Singapore from Jan 1, 2027 .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in